Atlas Trials

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Clinical trial NCT04277897 · UNKNOWN

Trial details

NCT number
NCT04277897
Sponsor
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis b
Start date
2020-03-15
Primary completion
2020-06-30
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.